2,4,5-TRIMETHOXYAMPHETAMIN

CAS No.
1083-09-6
Chemical Name:
2,4,5-TRIMETHOXYAMPHETAMIN
Synonyms
TMA-2;2,4,5-TMA;TMA-2 USP/EP/BP;15995-72-9 (Hydrochloride);2,4,5-TRIMETHOXYAMPHETAMIN;2,4,5-Trimethoxyamphetamine;2,4,5-trimethoxyphenylisopropylamine;2,4,5-TRIMETHOXYAMPHETAMIN, >99% (HPLC);1-(2,4,5-Trimethoxyphenyl)-2-propanamine;2,4,5-Trimethoxy-α-methylbenzeneethanamine
CBNumber:
CB01267934
Molecular Formula:
C12H19NO3
Molecular Weight:
225.29
MDL Number:
MFCD01707971
MOL File:
1083-09-6.mol
Last updated:2023-04-10 09:29:32

2,4,5-TRIMETHOXYAMPHETAMIN Properties

Melting point 130 °C
Boiling point 329.5±37.0 °C(Predicted)
Density 1.048±0.06 g/cm3(Predicted)
solubility DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml; PBS (pH 7.2): 10 mg/ml
pka 9.54±0.10(Predicted)
EWG's Food Scores 1
FDA UNII 713Z3SL0TJ

2,4,5-TRIMETHOXYAMPHETAMIN Chemical Properties,Uses,Production

Uses

TMA-2, known more formally as 2,4,5-trimethoxy-amphetamine, is a psychedelic hallucinogen which has appeared on the illicit drug market. Unlike amphetamines and cathinones, TMA-2 has no effect on monoamine re-uptake. TMA has modest effects on the 5-HT2 serotonin receptors (pEC50 values of 5.15 and 5.31 M for phosphatidylinositol release through 5-HT2A and 5HT2C, respectively). This product is intended for research and forensic applications.[Cayman Chemical]

4460-86-0
1083-09-6
Synthesis of 2,4,5-TRIMETHOXYAMPHETAMIN from 2,4,5-Trimethoxybenzaldehyde

2,4,5-TRIMETHOXYAMPHETAMIN Preparation Products And Raw materials

2,4,5-TRIMETHOXYAMPHETAMIN 2,4,5-trimethoxyphenylisopropylamine 2,4,5-TRIMETHOXYAMPHETAMIN, >99% (HPLC) 1-(2,4,5-Trimethoxyphenyl)-2-propanamine 2,4,5-TMA 2,4,5-Trimethoxyamphetamine 2,4,5-Trimethoxy-α-methylbenzeneethanamine TMA-2 α-Methyl-2,4,5-trimethoxybenzeneethanamine 15995-72-9 (Hydrochloride) 2,4,5-Trimethoxy-alpha-methylbenzeneethanamine 2,4,5-Trimethoxy-alpha-methylphenethylamine Phenethylamine, 2,4,5-trimethoxy-alpha-methyl- Phenethylamine, alpha-methyl-2,4,5-trimethoxy- Benzeneethanamine, 2,4,5-trimethoxy-α-methyl- TMA-2 USP/EP/BP 1083-09-6